| Model Number |
N/A |
| Medical Device Problem Code |
Use of Device Problem (1670)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
08/09/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
An outside of the united states (ous) customer contacted the siemens regional support center to report a falsely depressed activated partial thromboplastin time (aptt) result measured with the dade® actin® fsl activated ptt reagent on a sysmex cs-2500 system.The result was flagged with two errors that per the cs-2500 instructions for use, instructed the customer to reanalyze the sample.Siemens is investigating.
|
| |
|
Event or Problem Description
|
|
The customer reported the observation of a falsely depressed activated partial thromboplastin time (aptt) result measured with the dade® actin® fsl activated ptt reagent on a sysmex cs-2500 system.The erroneous result was flagged with two error codes and was reported to the physician(s).The patient was administered 5000 i/u heparin which was later determined to have been unnecessary.
|
| |
|
Additional Manufacturer Narrative
|
|
Siemens filed the initial mdr 9610806-2024-00037 on 23-sep2024.Additional information 20-oct-2024: siemens evaluated this issue and provided the following conclusion: based on review of the data and kinetic analysis, the result was appropriately flagged with 'slight coagulation' and 'coag% changed'.The user disregarded the flags and did not follow the 'corrective actions / counter measures' for the flags as published in the cs-2500 instructions for use manual.Cs-2500 actin fsl lot 562761a is performing as intended.A product performance issue has not been identified.No further evaluation of the device is required.In section h6, the investigation findings and investigation conclusions codes were updated.
|
| |
|
Search Alerts/Recalls
|